Heron Therapeutics reported $11.46M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
ALKERMES ALKS:US USD 201.73M 16.13M
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
Amarin AMRN:US USD 65.94M 7.31M
Ani Pharmaceuticals ANIP:US USD 50.93M 12.37M
Eisai 4523:JP JPY 129.23B 7.63B
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
GlaxoSmithKline GSK:LN GBP 5.44B 650M
Insmed INSM:US USD 54.26M 5.43M
JAZZ PHA JAZZ:US USD 806.99M 1.68M
Merk MRK:US USD 11.52B 1.08B
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Neurocrine Biosciences NBIX:US USD 381.8M 8.4M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M
Ultragenyx Pharmaceutical RARE:US USD 82.07M 999K
Veracyte VCYT:US USD 49.58M 1.75M
Vertex Pharmaceuticals VRTX:US USD 2.04B 110.5M